Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2022-06-22 00:00:00 ET · period of report 2022-06-17 · accession 0001567619-22-013252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-22 | 2022-06-17 | RVMD | Kelsey Stephen Michael | See Remarks | S - Sale | $17.75 | -1,145 | 290.1K | -0.4% | -$20.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-17 | S | D | 1,145 | $17.75 | 290,086 | D | — | — | (F3) Includes 46,688 RSUs. (F2) Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022. |